FDA inspection

Biohaven Pharmaceuticals, Inc: FDA inspection ending Nov 7, 2019

FDA inspection 1112681 · Voluntary Action Indicated (VAI) · New Haven, CT

Key facts

Inspection ID 1112681
Firm Biohaven Pharmaceuticals, Inc
FEI number 3010802167
Address 215 Church St
City New Haven
State CT
ZIP 06510
Country United States
Fiscal year 2020
Inspection end date Nov 7, 2019
Classification Voluntary Action Indicated (VAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections